Trial Profile
Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada for PrEP: A Nested Case Control Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 11 May 2021 Status changed from recruiting to completed.
- 06 Jan 2021 Planned End Date changed from 1 Dec 2021 to 1 Apr 2021.
- 06 Jan 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Apr 2021.